1h Free Analyst Time
The publisher has been monitoring the neurovascular devices market and it is poised to grow by $955.15 mn during 2022-2026, progressing at a CAGR of 5.44% during the forecast period. The report on the neurovascular devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the availability of favorable reimbursement coverage, outsourcing neurovascular devices research to CROs, and increasing incidence of aneurysms.
The neurovascular devices market analysis includes the product segment and geographic landscape.
The neurovascular devices market is segmented as below:
By Product
- Embolization devices
- Revascularization devices
- Embolic protection devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the market expansion in emerging economies as one of the prime reasons driving the neurovascular devices market growth during the next few years. Also, new technological advancements and the growing number of clinical trials will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on neurovascular devices market covers the following areas:
- Neurovascular devices market sizing
- Neurovascular devices market forecast
- Neurovascular devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurovascular devices market vendors that include Acandis GmbH, Asahi Intecc Co. Ltd., BALT Group, Cerus Endovascular Inc., Evasc Medical Systems Corp., Imperative Care, Integer Holdings Corp., Integra LifeSciences Corp., Johnson and Johnson Inc., Kaneka Corp., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., Penumbra Inc., Perflow Medical Ltd., phenox GmbH, Rapid Medical, SENSOME, Stryker Corp., and Terumo Corp. Also, the neurovascular devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher announces the Publication of its Research Report - Global Neurovascular Devices Market 2022-2026The publisher recognizes the following companies as the key players in the global neurovascular devices market: Acandis GmbH, Asahi Intecc Co. Ltd., BALT Group, Cerus Endovascular Inc., Evasc Medical Systems Corp., Imperative Care, Integer Holdings Corp., Integra LifeSciences Corp., Johnson and Johnson Inc., Kaneka Corp., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., Penumbra Inc., Perflow Medical Ltd., phenox GmbH, Rapid Medical, SENSOME, Stryker Corp., and Terumo Corp.
Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is market expansion in emerging economies.'
According to the report, one of the major drivers for this market is the availability of favorable reimbursement coverage.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- BALT Group
- Cerus Endovascular Inc.
- Evasc Medical Systems Corp.
- Imperative Care
- Integer Holdings Corp.
- Integra LifeSciences Corp.
- Johnson and Johnson Inc.
- Kaneka Corp.
- Lepu Medical Technology (Beijing) Co. Ltd.
- Medtronic Plc
- MicroPort Scientific Corp.
- Penumbra Inc.
- Perflow Medical Ltd.
- phenox GmbH
- Rapid Medical
- SENSOME
- Stryker Corp.
- Terumo Corp.
